Carregant...
Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
Intravenous (IV) iron is the therapy of choice when oral iron is ineffective or poorly tolerated, yet use has been limited by fears of hypersensitivity reactions (HSRs). Newer formulations that bind iron more tightly and release it more slowly have made the risk of serious or severe HSRs very low. O...
Guardat en:
| Publicat a: | Am J Hematol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248147/ https://ncbi.nlm.nih.gov/pubmed/33580972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.26124 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|